Communiqués

20/08 Light AI announces Voting Results from its Annual General Meeting AQ
18/08 Light AI reports Financial Results for Three and Six Months ended June 30, 2026 AQ
12/08 Light AI Receives Health Canada Medical Device License for QuickScan™ Strep A AQ
29/06 LIGHT AI ACHIEVES ISO 13485 AND MDSAP CERTIFICATION, ADVANCING REGULATORY READINESS FOR HEALTH CANADA SUBMISSION OF QUICKSCAN™ SOFTWARE PLATFORM AQ
25/06 Light AI Appoints Director AQ
20/06 Light AI Announces Closing of C$5,000,000 Secured Convertible Debenture Unit Financing AQ
16/06 LIGHT AI ANNOUNCES COMPANY-FUNDED FIELD STUDY IN NEW ZEALAND FOR QUICKSCAN™ STREP A PLATFORM AQ
10/06 Light AI Announces Grant of Stock Options AQ
04/06 LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SaMD) AQ
21/05 Light AI Announces C$5,000,000 Secured Convertible Debenture Unit Financing AQ
16/05 Light AI reports Financial Results for Three Months ended March 31, 2026 AQ
01/05 Light AI Appoints CFO and Corporate Secretary AQ
27/03 Light AI reports Financial Results for Three Months and Year ended December 31, 2025 AQ
20/01 Light AI Appoints John R. Luna as Chief Executive Officer AQ
04/12 Light AI Technology Leadership Transition AQ
18/11 Light AI Version 1.0 Software Completion AQ
07/11 Light AI reports Financial Results for Three and Nine Months ended September 30, 2025 AQ
28/10/25 Light AI Expands Patent Portfolio AQ
21/10/25 Light AI announces New Director Appointments AQ
05/09/25 Light AI Announces Voting Results for Annual General Meeting AQ
15/08/25 Light AI reports Financial Results for Three and Six Months ended June 30, 2025 AQ
07/07/25 Light AI Wellness Application Q3 2025 Launch AQ
23/06/25 Light AI to Present at 25th Annual Healthcare Summit in Vancouver AQ
03/06/25 Emerging Markets Report: Shedding Some Light AQ
15/05/25 Light AI Reports Financial Results for Q1 2025 AQ
Aucun résultat pour cette recherche